CHCWM – Cancer & Hematology Centers of West Michigan

Zymeworks (ZWI-ZW25-201)

A Phase 2 Study of ZW25 Plus First-Line Combination Chemotherapy in HER2-Expression Gastrointestinal (GI) Cancers, Including Gastroesophageal Adenocarcinoma (GEA), Biliary tract Cancer (BTC), and Colorectal Cancer (CRC)

Principal Investigator: Dr. Sreenivasa Chandana

For more information on this trial, read its profile on clinicaltrials.gov here.